Medtronic plc (MDT)

NYQ – Real Time Price. Currency in USD

90.80

+0.12 (0.13%)

Market open: Aug 12, 2026, 2:12 PM EDT

90.50

-0.18 (-0.20%)

Previous after-hours: Aug 11, 2026, 7:58 PM EDT

08.08.2026

Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?

Medtronic has launched new devices that will help further improve its financial results. Intuitive Surgical's latest da Vinci system could expand its addressable market.

08.08.2026

I've Got Royalty on the Brain

And how could I not? After exploring Brighton Beach and Bristol, and then Cornwall all the way to St. Ives and Penzance, I wrapped up my Great Britain trip with a couple days in London.

06.08.2026

Stock Picks From Seeking Alpha's July 2026 New Analysts

Seeking Alpha welcomed 33 new analysts in July 2026. This article showcases their top picks and investment strategies. Highlighted companies include SELLAS Life Sciences, Chevron, B2Gold, Amazon, and QXO, each with detailed investment theses. Analysts emphasize asymmetric opportunities, event-driven catalysts, balance sheet strength, market structure, and sector-specific growth or risk factors.

06.08.2026

33 stocks to bet on foreign markets continuing to beat the S&P 500

Surprisingly, many foreign markets are way ahead of the U.S. in year-to-date performance.

06.08.2026

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

Sphere-9 all-in-one mapping and ablation, large-tip focal, dual energy catheter first to be CE Marked for ventricular ablation New indication marks important milestone for ventricular arrhythmia patients as positive physician sentiment and global expansion for Sphere ‑ 9 continue Sphere VT U.S. pivotal trial enrollment underway GALWAY, Ireland, Aug. 6, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced an expanded CE Mark indication for the Affera™ Mapping and Ablation System with Sphere-9™ Catheter to treat ventricular arrhythmias, including ventricular tachycardia (VT) and premature ventricular complexes (PVCs). The Sphere-9 catheter is the first all-in-one mapping and ablation, large-tip focal, dual-energy catheter CE marked for ventricular ablation.

05.08.2026

I'm Calling It: Medtronic (MDT) Will Soar 40% by the End of 2026

Medtronic's stock has slumped over the past five years. But its restructuring efforts could bring back the bulls.

03.08.2026

Medtronic (MDT) Laps the Stock Market: Here's Why

The latest trading day saw Medtronic (MDT) settling at $86.68, representing a +1.51% change from its previous close.

Videos

No Data

There is no data to display

Press releases

06.08.2026

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

Medtronic plc (MDT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Medtronic plc (MDT)

Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?

I've Got Royalty on the Brain

Stock Picks From Seeking Alpha's July 2026 New Analysts

33 stocks to bet on foreign markets continuing to beat the S&P 500

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

I'm Calling It: Medtronic (MDT) Will Soar 40% by the End of 2026

Medtronic (MDT) Laps the Stock Market: Here's Why

Videos

No Data

Press releases

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?

I've Got Royalty on the Brain

Stock Picks From Seeking Alpha's July 2026 New Analysts

33 stocks to bet on foreign markets continuing to beat the S&P 500

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

I'm Calling It: Medtronic (MDT) Will Soar 40% by the End of 2026

Medtronic (MDT) Laps the Stock Market: Here's Why

Videos

No Data

Press releases

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

Search stocks

Medtronic plc (MDT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Medtronic plc (MDT)

Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?

I've Got Royalty on the Brain

Stock Picks From Seeking Alpha's July 2026 New Analysts

33 stocks to bet on foreign markets continuing to beat the S&P 500

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

I'm Calling It: Medtronic (MDT) Will Soar 40% by the End of 2026

Medtronic (MDT) Laps the Stock Market: Here's Why

Videos

No Data

Press releases

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?

I've Got Royalty on the Brain

Stock Picks From Seeking Alpha's July 2026 New Analysts

33 stocks to bet on foreign markets continuing to beat the S&P 500

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

I'm Calling It: Medtronic (MDT) Will Soar 40% by the End of 2026

Medtronic (MDT) Laps the Stock Market: Here's Why

Videos

No Data

Press releases

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias